Evidence map›Paper›PMID 12825818›Full record

ArticleJournal of neuro-oncology2003

Cell density regulates thrombospondin-1 production in malignant glioma cells.

Hirofumi Naganuma, Eiji Satoh, Tomoyuki Kawataki, Kenichi Amagasaki, Hiroki Satoh, Hideaki Nukui

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hirofumi NaganumaDepartment of Neurosurgery University of Yamanashi Faculty of Medicine, Tamaho-machi, Nakakoma-gun, Yamanashi, Japan. naganuma@swallow.res.yamanashi-med.ac.jp
Eiji Satoh
Tomoyuki Kawataki
Kenichi Amagasaki
Hiroki Satoh
Hideaki Nukui
University of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombospondin-1 (TSP-1) is a multifunctional matrix protein implicated in cancer cell adhesion, migration, and invasion, inhibition of angiogenesis, and activation of latent transforming growth factor-beta (TGF-beta). The effect of cell density was investigated on the production of TSP-1, basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF) by two glioblastoma cell lines. The effect of TGF-beta was also examined. The amount of intracellular TSP-1 protein decreased significantly as the cell density increased in cultures of both T98G and A172 cells. The amount of intracellular TSP-1 was highest in sparse tumor cell cultures and lowest in densely confluent tumor cell cultures. The maximum reduction of TSP-1 protein production was 56.8% and 44.6% in T98G and A172 cells, respectively. The cell density did not affect the production of bFGF or VEGF. TGF-beta2 treatment did not affect the production of TSP-1, bFGF, or VEGF proteins. Treatment with excess TGF-beta2 resulted in a slight but significant decrease (22%; P < 0.02) of TGF-beta2 production by A172 cells, but not by T98G cells. The present results indicate that the production of TSP-1 protein is regulated by cell density of glioblastoma cells, while that of angiogenic factors is not affected by tumor cell density. This suggests that high tumor cell density may tilt the angiogenic balance in favor of angiogenesis.

Indexed as

Brain NeoplasmsCell CountCell DivisionEndothelial Growth FactorsFibroblast Growth Factor 2GlioblastomaHumansIntercellular Signaling Peptides and ProteinsLymphokinesNeovascularization, PathologicThrombospondin 1Transforming Growth Factor betaTumor Cells, CulturedVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsEndothelial Growth FactorsFibroblast Growth Factor 2Intercellular Signaling Peptides and ProteinsLymphokinesThrombospondin 1Transforming Growth Factor betaVascular Endothelial Growth Factor AVascular Endothelial Growth Factors

Identifiers

PMID12825818
OpenAlexW48176447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.